Clean Vision Corp (CLNV) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2711 N. SEPULVEDA BLVD MANHATTAN BEACH, CA 90266 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 286 - Industrial Organic Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 340 | |||
| Cash and cash equivalents | 340 | |||
| Receivables | 71 | |||
| Other undisclosed current assets | 442 | |||
| Total current assets: | 853 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 4,884 | |||
| Intangible assets, net (including goodwill) | 4,585 | |||
| Goodwill | 4,585 | |||
| Other undisclosed noncurrent assets | 270 | |||
| Total noncurrent assets: | 9,738 | |||
| TOTAL ASSETS: | 10,591 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 631 | |||
| Accounts payable | 287 | |||
| Accrued liabilities | 344 | |||
| Debt | 3,132 | |||
| Derivative instruments and hedges, liabilities | 598 | |||
| Other undisclosed current liabilities | 6,444 | |||
| Total current liabilities: | 10,806 | |||
| Noncurrent Liabilities | ||||
| Liabilities, other than long-term debt | 589 | |||
| Derivative instruments and hedges, liabilities | 589 | |||
| Other undisclosed noncurrent liabilities | 1,161 | |||
| Total noncurrent liabilities: | 1,750 | |||
| Total liabilities: | 12,556 | |||
| Equity | ||||
| Equity, attributable to parent | (5,438) | |||
| Common stock | 682 | |||
| Additional paid in capital | 26,592 | |||
| Accumulated other comprehensive income | 2 | |||
| Accumulated deficit | (32,714) | |||
| Other undisclosed equity, attributable to parent | ||||
| Equity, attributable to noncontrolling interest | 1,453 | |||
| Other undisclosed equity | 2,020 | |||
| Total equity: | (1,965) | |||
| TOTAL LIABILITIES AND EQUITY: | 10,591 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | ||
|---|---|---|---|
| Revenues | 257 | ||
| Cost of revenue | (1,614) | ||
| Cost of goods and services sold | (1,614) | ||
| Other undisclosed gross profit | 1,519 | ||
| Gross profit: | 163 | ||
| Operating expenses | (8,362) | ||
| Other undisclosed operating loss | |||
| Operating loss: | (8,199) | ||
| Nonoperating expense | (4,081) | ||
| Interest and debt expense | (5,478) | ||
| Loss from continuing operations before equity method investments, income taxes: | (17,758) | ||
| Other undisclosed income from continuing operations before income taxes | 5,478 | ||
| Net loss: | (12,280) | ||
| Net loss attributable to noncontrolling interest | (12,280) | ||
| Other undisclosed net income attributable to parent | 12,265 | ||
| Net loss attributable to parent: | (12,294) | ||
| Other undisclosed net income available to common stockholders, basic | |||
| Net loss available to common stockholders, diluted: | (12,294) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | ||
|---|---|---|---|
| Net loss: | (12,280) | ||
| Comprehensive loss: | (12,280) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (12,265) | ||
| Comprehensive loss, net of tax, attributable to parent: | (24,545) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.